Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury

Molecular Brain Research

Volumn 134, Issue 1, 2005, Pages 147-154

  Canudas, Anna M ^a,b   Pezzi, Susana ^a   Canals, Josep M ^a   Pallàs, Mercè ^b   Alberch, Jordi ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Basal ganglia; Kainate; Neurotrophins; Rat; Substantia nigra; trkB IgG

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G; KAINIC ACID; TYROSINE 3 MONOOXYGENASE;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATROPHY; AUTOCRINE EFFECT; BRAIN INJURY; CELL COUNT; CELL PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EXCITOTOXICITY; MALE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STATISTICAL SIGNIFICANCE; SUBSTANTIA NIGRA; UPREGULATION;

EID: 15544373279     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.11.012     Document Type: Article

References (40)

1. E. Aliaga, F. Rage, L. Tapia-Arancibia, and G. Bustos Negative regulation of brain-derived neurotrophic factor mRNA expression by kainic acid in substantia nigra Mol. Brain Res. 71 1999 341 344
2. E. Aliaga, C. Carcamo, J. Abarca, L. Tapia-Arancibia, and G. Bustos Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway Mol. Brain Res. 79 2000 150 155
3. C.A. Altar, C.B. Boylan, M. Fritsche, B.E. Jones, C. Jackson, S.J. Wiegand, R.M. Lindsay, and C. Hyman Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions J. Neurochem. 63 1994 1021 1032
4. P.E. Batchelor, G.T. Liberatore, M.J. Porritt, G.A. Donnan, and D.W. Howells Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum Eur. J. Neurosci. 12 2000 3462 3468
5. D.K. Binder, M.J. Routbort, T.E. Ryan, G.D. Yancopoulos, and J.O. McNamara Selective inhibition of kindling development by intraventricular administration of TrkB receptor body J. Neurosci. 19 1999 1424 1436
6. J.M. Canals, S. Marco, N. Checa, A. Michels, E. Perez-Navarro, E. Arenas, and J. Alberch Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease Neurobiol. Dis. 5 1998 357 364
7. J.M. Canals, N. Checa, S. Marco, P. Akerud, A. Michels, E. Perez-Navarro, E. Tolosa, E. Arenas, and J. Alberch Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area J. Neurosci. 21 2001 117 124
8. N. Checa, J.M. Canals, and J. Alberch Developmental regulation of BDNF and NT-3 expression by quinolinic acid in the striatum and its main connections Exp. Neurol. 165 2000 118 124
9. N. Checa, J.M. Canals, E. Gratacos, and J. Alberch TrkB and TrkC are differentially regulated by excitotoxicity during development of the basal ganglia Exp. Neurol. 172 2001 282 292
10. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
11. B.F. El Khodor, and R.E. Burke Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons J. Comp. Neurol. 452 2002 65 79
12. P. Fort, L. Marty, M. Piechaczyk, S. el Sabrouty, C. Dani, P. Jeanteur, and J.M. Blanchard Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family Nucleic Acids Res. 13 1985 1431 1442
13. C.M. Gall, S.J. Gold, P.J. Isackson, and K.B. Seroogy Brain-derived neurotrophic factor and neurotrophin-3 messenger-Rnas are expressed in ventral midbrain regions containing dopaminergic-neurons Mol. Cell. Neurosci. 3 1992 56 63
14. K.M. Giehl, A. Schutte, P. Mestres, and Q. Yan The survival-promoting effect of glial cell line-derived neurotrophic factor on axotomized corticospinal neurons in vivo is mediated by an endogenous brain-derived neurotrophic factor mechanism J. Neurosci. 18 1998 7351 7360
15. T. Hagg Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo Exp. Neurol. 149 1998 183 192
16. C. Hyman, M. Hofer, Y.A. Barde, M. Juhasz, G.D. Yancopoulos, S.P. Squinto, and R.M. Lindsay BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 350 1991 230 232
17. C. Hyman, M. Juhasz, C. Jackson, P. Wright, N.Y. Ip, and R.M. Lindsay Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon J. Neurosci. 14 1994 335 347
18. E.B. Krammer Anterograde and transsynaptic degeneration 'en cascade' in basal ganglia induced by intrastriatal injection of kainic acid: an animal analogue of Huntington's disease Brain Res. 196 1980 209 221
19. M.A. Laurenzi, G. Barbany, T. Timmusk, J.A. Lindgren, and H. Persson Expression of mRNA encoding neurotrophins and neurotrophin receptors in rat thymus, spleen tissue and immunocompetent cells. Regulations of neurotrophin-4 mRNA expression by mitogens and leukotriene B4 Eur. J. Biochem. 223 1994 733 741
20. N. Lindefors, E. Brondin, and M. Metsis Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock Neuroscience 65 1995 661 670
21. A. Macaya, F. Munell, R.M. Gubits, and R.E. Burke Apoptosis in substantia nigra following developmental striatal excitotoxic injury Proc. Natl. Acad. Sci. U. S. A. 91 1994 8117 8121
22. S. Marco, A.M. Canudas, J.M. Canals, N. Gavalda, E. Perez-Navarro, and J. Alberch Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum Exp. Neurol. 174 2002 243 252
23. S. Marco, J. Saura, E. Perez-Navarro, M.J. Marti, E. Tolosa, and J. Alberch Regulation of c-Ret, GFR alpha 1, and GFR alpha 2 in the substantia nigra Pars compacta in a rat model of Parkinson's disease J. Neurobiol. 52 2002 343 351
24. M.J. Marti, C.J. James, T.F. Oo, W.J. Kelly, and R.E. Burke Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra J. Neurosci. 17 1997 2030 2039
25. T.F. Oo, and R.E. Burke The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra Dev. Brain Res. 98 1997 191 196
26. T.F. Oo, N. Kholodilov, and R.E. Burke Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo J. Neurosci. 23 2003 5141 5148
27. E. Perez-Navarro, J. Alberch, I. Neveu, and E. Arenas Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo Neuroscience 91 1999 1257 1264
28. E. Perez-Navarro, A.M. Canudas, P. Akerund, J. Alberch, and E. Arenas Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease J. Neurochem. 75 2000 2190 2199
29. I. Rite, J.L. Venero, M. Tomas-Camardiel, A. Machado, and J. Cano Expression of BDNF mRNA in substantia nigra is dependent on target integrity and independent of neuronal activation J. Neurochem. 87 2003 709 721
30. J. Sautter, M. Meyer, C. Spenger, R.W. Seiler, and H.R. Widmer Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons NeuroReport 9 1998 1093 1096
31. K.B. Seroogy, and C.M. Gall Expression of neurotrophins by midbrain dopaminergic-neurons Exp. Neurol. 124 1993 119 128
32. K.B. Seroogy, K.H. Lundgren, T.M. Tran, K.M. Guthrie, P.J. Isackson, and C.M. Gall Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs J. Comp. Neurol. 342 1994 321 334
33. D.E. Smith, M. Saji, T.H. Joh, D.J. Reis, and V.M. Pickel Ibotenic acid-induced lesions of striatal target and projection neurons: ultrastructural manifestations in dopaminergic and non-dopaminergic neurons and in glia Histol. Histopathol. 2 1987 251 263
34. M.B. Spina, S.P. Squinto, J. Miller, R.M. Lindsay, and C. Hyman Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system J. Neurochem. 59 1992 99 106
35. L. Stefanis, and R.E. Burke Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution, and morphology of cell death Neuroscience 74 1996 997 1008
36. A. Tomac, E. Lindqvist, L.F. Lin, S.O. Ogren, D. Young, B.J. Hoffer, and L. Olson Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo Nature 373 1995 335 339
37. J.L. Venero, K.D. Beck, and F. Hefti 6-Hydroxydopamine lesions reduce BDNF messenger RNA levels in adult rat brain substantia nigra NeuroReport 5 1994 429 432
38. J.L. Venero, M.L. Vizuete, M. Revuelta, C. Vargas, J. Cano, and A. Machado Upregulation of BDNF mRNA and trkB mRNA in the nigrostriatal system and in the lesion site following unilateral transection of the medial forebrain bundle Exp. Neurol. 161 2000 38 48
39. D.M. Yurek, and A. Fletcher-Turner Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion Brain Res. 891 2001 228 235
40. J.W. Zhou, Y. Yu, Z.S. Tang, Y. Shen, and L. Xu Differential expression of mRNAs of GDNF family in the striatum following 6-OHDA-induced lesion NeuroReport 11 2000 3289 3293